FHTX
FHTX
US3441741077
Foghorn Therapeutics Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
118.77M EUR
286.53M EUR
280.64M EUR
305.95M EUR
Enterprise Value
-6.3M EUR
261.55M EUR
234.97M EUR
266.34M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-1.95x
--
--
--
Price to Sales
3.23x
7.8x
9.94x
12.26x
Price to Book
--
--
--
--
EV/Revenue
-0.17x
7.12x
8.33x
10.67x
EV/EBITDA
0.1x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-43.74%
-29.42%
-31.15%
-20.31%
ende